| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1996;27:56-61.)
© 1996 American Heart Association, Inc.
Articles |
Plasma of Preeclamptic Women Stimulates and Then Inhibits Endothelial Prostacyclin
From the Magee-Womens Research Institute and Departments of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh (Pa), and Gensia, Inc, San Diego, Calif (J.B.).
Correspondence to J.M. Roberts, Magee-Womens Research Institute, 204 Craft Ave, Pittsburgh, PA 15213.
Abstract We propose that the dichotomy between the in vivo reduction in intravascular prostacyclin production that occurs in preeclampsia and the in vitro stimulatory effect of plasma from preeclamptic patients on endothelial cell prostacyclin production is due to differential effects of chronic versus acute exposure to the plasma. We studied the acute versus chronic effects of 2% plasma from healthy pregnant and preeclamptic subjects by measuring endothelial prostacyclin production at different time periods after exposure to plasma. To determine whether such effects were specific to prostacyclin, we also measured prostaglandin E2 production. To determine whether chronic changes in prostacyclin production resulted from altered cellular responsiveness, we stimulated cells that had been exposed to plasma for 72 hours with arachidonic acid and measured prostaglandin production. Preliminary characterization of the plasma factor or factors responsible for alterations in prostaglandin production was performed. After 24 hours cells exposed to plasma from preeclamptic women produced more prostacyclin and prostaglandin E2 than cells exposed to plasma from healthy pregnant women. In contrast, after 72 hours exposure to plasma from preeclamptic women resulted in less endothelial cell prostacyclin production than exposure to plasma from healthy pregnant women, but there were no such differences in prostaglandin E2 production. Cells that had been exposed to plasma from preeclamptic women for 72 hours produced less prostacyclin but the same quantity of prostaglandin E2 after stimulation with arachidonic acid than cells exposed to plasma from healthy pregnant women. The plasma factor or factors responsible for altered prostacyclin production were sensitive to heat, acid, and proteases. In contrast to acute exposure, chronic exposure to plasma from preeclamptic women alters endothelial cells to result in decreased prostacyclin production, an observation consistent with in vivo findings.
Key Words: endothelium • prostacyclin • preeclampsia • pregnancy
This article has been cited by other articles:
 |
|
 |
|
  S. Sankaralingam, H. Xu, and S. T. Davidge Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia Cardiovasc Res, September 3, 2009; (2009) cvp277v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Collino, B. Bussolati, E. Gerbaudo, L. Marozio, S. Pelissetto, C. Benedetto, and G. Camussi Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1185 - F1194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Roberts, B. B. D. LaMarca, L. Fournier, J. Bain, K. Cockrell, and J. P. Granger Enhanced Endothelin Synthesis by Endothelial Cells Exposed to Sera From Pregnant Rats With Decreased Uterine Perfusion Hypertension, March 1, 2006; 47(3): 615 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Donker, S. A. Asgeirsdottir, F. Gerbens, M. G. van Pampus, C. G. M. Kallenberg, G. J. t. Meerman, J. G. Aarnoudse, and G. Molema Plasma Factors in Severe Early-Onset Preeclampsia Do Not Substantially Alter Endothelial Gene Expression In Vitro Reproductive Sciences, February 1, 2005; 12(2): 98 - 106. [Abstract] [PDF]
|
|
|
|
 |
|
 R. A. Khalil and J. P. Granger Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R29 - R45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. GREEN, S. ASSADY, F. NAKHOUL, T. BICK, P. JAKOBI, and Z. ABASSI Differential Effects of Sera from Normotensive and Hypertensive Pregnant Women on Ca2+ Metabolism in Normal Vasular Smooth Muscle Cells J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1188 - 1198. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Dechend, V. Homuth, G. Wallukat, J. Kreuzer, J. K. Park, J. Theuer, A. Juepner, D. C. Gulba, N. Mackman, H. Haller, et al. AT1 Receptor Agonistic Antibodies From Preeclamptic Patients Cause Vascular Cells to Express Tissue Factor Circulation, May 23, 2000; 101(20): 2382 - 2387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Hubel Oxidative Stress in the Pathogenesis of Preeclampsia Experimental Biology and Medicine, December 1, 1999; 222(3): 222 - 235. [Abstract] [Full Text]
|
|
|
|
|
|
R. Hayman, J. Brockelsby, L. Kenny, and P. Baker Preeclampsia: The Endothelium, Circulating Factor(s) and Vascular Endothelial Growth Factor Reproductive Sciences, January 1, 1999; 6(1): 3 - 10. [Abstract] [PDF]
|
|
|
|
|
|
S. Khatun, N. Kanayama, E. Sato, H. M. Belayet, T. Kobayashi, and T. Terao Eclamptic Plasma Stimulates Norepinephrine Release in Cultured Sympathetic Nerve Hypertension, June 1, 1998; 31(6): 1343 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Wellings, J. C. Brockelsby, and P. N. Baker Activation of Endothelial Cells by Plasma From Women With Preeclampsia: Differential Effects on Four Endothelial Cell Types Reproductive Sciences, January 1, 1998; 5(1): 31 - 37. [Abstract] [PDF]
|
|
|
|
|
|
H. Haller, E.-M. Ziegler, V. Homuth, M. Drab, J. Eichhorn, Z. Nagy, A. Busjahn, K. Vetter, and F. C. Luft Endothelial Adhesion Molecules and Leukocyte Integrins in Preeclamptic Patients Hypertension, January 1, 1997; 29(1): 291 - 296. [Abstract] [Full Text] [PDF]
|
|